Clinical Trial

Reinforcement Learned Automated Anesthesia Systems During Painless Abortion

Study acronym: AAS-PA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2025 (before its estimated October 8, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study compares the automated anesthesia systems for painless abortion (AAS-PA) with traditional anesthesia in painless abortions. It assesses intraoperative indicators (hypoxemia, injection pain, hypotension, hemodynamics, respiratory depression) and postoperative outcomes (nausea, dizziness, recovery time, satisfaction). The AAS-PA group uses AI-adjusted intravenous ciprofol based on real-time vital signs and sedation depth; the traditional group relies on manual anesthesia. The goal is to verify if AAS-PA safely manages sedation, meets painless standards, reduces adverse events, and improves experience, aiding optimized automated protocols.
Trial Details
NCT Number NCT07132151
Lead Sponsor Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Collaborators: Fujian Provincial Hospital, Shishi Hospital, Sichuan Provincial People's Hospital, First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University, The People's Hospital of Yubei District of Chongqing city, Peking University Shenzhen Hospital, People's Hospital of Zhengzhou University, Jinjiang Municipal Hospital (Shanghai Sixth People's Hospital Fujian)
Conditions Painless Abortion, Artificial Intelligence (AI), Ciprofol
Enrollment 167 participants
Start Date 2025-09-08
Primary Completion 2025-10-08 (estimated)
Study Completion 2027-11-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-20